Company
ViaNautis
Revolutionising cell and gene therapy with polyNaut®
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, United Kingdom
- Founded
- 2018
- vianautis.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 17 September 2026
About
ViaNautis is transforming cell and gene therapy with polyNaut®, a versatile, non-viral, targeted polymer-based nanovesicles delivery system that enables precise, plug-and-play targeting to cells in the central nervous system, lung, and immune system.
Funding snapshot
- Total raised
- $25MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $25M
Funding rounds
- Seed
- Recorded
- Series A
- $25MCompany stated
Products
- Other
- polyNaut®
Loading relationship preview